AU4145597A - Ulcerative colitis panca secretory vesicle antigen and methods of using sa me - Google Patents

Ulcerative colitis panca secretory vesicle antigen and methods of using sa me

Info

Publication number
AU4145597A
AU4145597A AU41455/97A AU4145597A AU4145597A AU 4145597 A AU4145597 A AU 4145597A AU 41455/97 A AU41455/97 A AU 41455/97A AU 4145597 A AU4145597 A AU 4145597A AU 4145597 A AU4145597 A AU 4145597A
Authority
AU
Australia
Prior art keywords
methods
ulcerative colitis
secretory vesicle
vesicle antigen
panca secretory
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU41455/97A
Inventor
Jonathan Braun
Mark Eggena
Lynn K. Gordon
Stephan R Targan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cedars Sinai Medical Center
University of California
Original Assignee
Cedars Sinai Medical Center
University of California
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cedars Sinai Medical Center, University of California filed Critical Cedars Sinai Medical Center
Publication of AU4145597A publication Critical patent/AU4145597A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4713—Autoimmune diseases, e.g. Insulin-dependent diabetes mellitus, multiple sclerosis, rheumathoid arthritis, systemic lupus erythematosus; Autoantigens
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Rheumatology (AREA)
  • Rehabilitation Therapy (AREA)
  • Diabetes (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
AU41455/97A 1997-02-20 1997-08-06 Ulcerative colitis panca secretory vesicle antigen and methods of using sa me Abandoned AU4145597A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US80410697A 1997-02-20 1997-02-20
US08804106 1997-02-20
PCT/US1997/013059 WO1998037415A1 (en) 1997-02-20 1997-08-06 ULCERATIVE COLITIS pANCA SECRETORY VESICLE ANTIGEN AND METHODS OF USING SAME

Publications (1)

Publication Number Publication Date
AU4145597A true AU4145597A (en) 1998-09-09

Family

ID=25188201

Family Applications (1)

Application Number Title Priority Date Filing Date
AU41455/97A Abandoned AU4145597A (en) 1997-02-20 1997-08-06 Ulcerative colitis panca secretory vesicle antigen and methods of using sa me

Country Status (2)

Country Link
AU (1) AU4145597A (en)
WO (1) WO1998037415A1 (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3521382B2 (en) 1997-02-27 2004-04-19 日本たばこ産業株式会社 Cell surface molecules that mediate cell-cell adhesion and signal transduction
US7112655B1 (en) 1997-02-27 2006-09-26 Japan Tobacco, Inc. JTT-1 protein and methods of inhibiting lymphocyte activation
JP3871503B2 (en) 1999-08-30 2007-01-24 日本たばこ産業株式会社 Immune disease treatment
JP4210454B2 (en) 2001-03-27 2009-01-21 日本たばこ産業株式会社 Inflammatory bowel disease treatment
JP3597140B2 (en) 2000-05-18 2004-12-02 日本たばこ産業株式会社 Human monoclonal antibody against costimulatory molecule AILIM and pharmaceutical use thereof
JP4212278B2 (en) 2001-03-01 2009-01-21 日本たばこ産業株式会社 Graft rejection inhibitor
US7759079B2 (en) 2004-05-13 2010-07-20 Prometheus Laboratories Inc. Methods of diagnosing inflammatory bowel disease
US7873479B2 (en) 2005-12-01 2011-01-18 Prometheus Laboratories Inc. Methods of diagnosing inflammatory bowel disease
US8685741B1 (en) 2007-03-07 2014-04-01 Nestec S.A. Methods for diagnosing irritable bowel syndrome
NZ619527A (en) 2009-04-14 2015-06-26 Nestec Sa Inflammatory bowel disease prognostics
JP2015502740A (en) 2011-10-21 2015-01-29 ネステク ソシエテ アノニム Methods for improving the diagnosis of inflammatory bowel disease

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5292667A (en) * 1988-06-29 1994-03-08 The General Hospital Corporation Detection and treatment of ulcerative colitis
US5691151A (en) * 1994-10-07 1997-11-25 Regents Of University Of California Methods of screening for ulcerative colitis and crohn's disease by detecting VH3-15 autoantibody and panca

Also Published As

Publication number Publication date
WO1998037415A1 (en) 1998-08-27

Similar Documents

Publication Publication Date Title
AU4983096A (en) Modular chair construction and method of assembly
AU4394193A (en) Improved building wall and method of constructing same
AU8169498A (en) Backpack assembly and method of use
AU7448691A (en) Buildings and methods of constructing buildings
AU654985B2 (en) Mortarless construction method and element
AU5719796A (en) Male erection facilitation sheaths and methods of use thereof
AU7243396A (en) Peanut allergens and methods
AU6987391A (en) Wall panels and methods of construction thereof
AU8063798A (en) Secretory immunoglobulin produced by single cells and methods for making and using same
AU6146596A (en) Lower-energy hydrogen methods and structures
EP1034288A4 (en) Methods of isolating and using cd7+cd34-lin-hematopoietic cells
AU4145597A (en) Ulcerative colitis panca secretory vesicle antigen and methods of using sa me
AU7422496A (en) NM03 antibody materials and methods
AP9701131A0 (en) Wall construction and method of manufacturing
AU2550697A (en) Thermoplastic positioning sling and method of fabrication thereof
AU4455796A (en) Pre-cast building methods and components
AU4976697A (en) T cells mediating an immune response and methods of use
AU6241996A (en) Assay method and assay kit
AU5801896A (en) Antigen-specific activation of unprimed cd8+ t cells
AU5425194A (en) Detection of anti-hpa antibodies
IL118428A0 (en) Ethylamido fluorenes and improved method of making same
AU2902295A (en) Heat-seamable thermoset sheeting membrane and methods of manufacturing and using same
AU672569B3 (en) Building structures and construction methods
AU7545596A (en) Building element joint structure and method
AU6555196A (en) Improved building and method of construction